Drug company movers & shakers advertising in professional health journals in Q1 2013
Among the top 25 drug companies advertising in professional health journals, these are some of the fastest growing in terms of print journal advertising year-to-date in 2013 as compared with that time period last year.
Print Ad Drug Companies with Large Increases (Dollars): Jan. – Mar. 2013
- Sunovion Inc. – $1 MM (+106%)
- Celegene Corporation – $1 MM (+246%)
- Boehringer Ingelheim Corporate – $1 MM (+84%)
- Medivation and Astellas – $1 MM (+383%)
- Daiichi Sankyo and Lilly USA – $961,000 (+128%)
Medivation and Astellas jumped into the top five due to advertising of the product Xtandi, which launched late 2012.
Daiichi Sankyo and Lilly USA made the top 5 in terms of percent change in the first quarter due to the increase in advertising of Effient. In 2012, Daiichi Sankyo and Lilly USA ramped up advertising in Effient near the end of the year as opposed to Q1.
Celegene ranked #2 this quarter because of an increase in advertising of Abraxane Injectable.
The percentage changes compare Q1 2013 to Q1 2012. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.